American Century Companies’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $146K | Sell |
16,331
-121,382
| -88% | -$1.09M | ﹤0.01% | 2773 |
|
|
2025
Q1 | $1.03M | Sell |
137,713
-17,332
| -11% | -$130K | ﹤0.01% | 2242 |
|
|
2024
Q4 | $1.17M | Sell |
155,045
-330
| -0.2% | -$2.48K | ﹤0.01% | 2210 |
|
|
2024
Q3 | $1.18M | Buy |
155,375
+6,885
| +5% | +$52.3K | ﹤0.01% | 2178 |
|
|
2024
Q2 | $918K | Buy |
148,490
+133,591
| +897% | +$826K | ﹤0.01% | 2198 |
|
|
2024
Q1 | $75.7K | Hold |
14,899
| – | – | ﹤0.01% | 2880 |
|
|
2023
Q4 | $89.2K | Hold |
14,899
| – | – | ﹤0.01% | 2821 |
|
|
2023
Q3 | $105K | Hold |
14,899
| – | – | ﹤0.01% | 2717 |
|
|
2023
Q2 | $105K | Sell |
14,899
-51
| -0.3% | -$359 | ﹤0.01% | 2671 |
|
|
2023
Q1 | $125K | Sell |
14,950
-192
| -1% | -$1.61K | ﹤0.01% | 2512 |
|
|
2022
Q4 | $174K | Buy |
+15,142
| New | +$174K | ﹤0.01% | 2361 |
|
|
2022
Q2 | – | Sell |
-59,450
| Closed | -$967K | – | 2313 |
|
|
2022
Q1 | $967K | Buy |
59,450
+19,419
| +49% | +$316K | ﹤0.01% | 1690 |
|
|
2021
Q4 | $554K | Buy |
+40,031
| New | +$554K | ﹤0.01% | 1881 |
|